Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar Desai, MD
Kappa-Opioid Settings: Real-World Evidence Insights
Lucio Manenti, MD, PhD
Emilio Sanchez, MD, PhD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
James Burton, DM, FRCP
Leonie Kraft, MD
Improving Sleep and Mental Health in Patients with CKD-aP
Is CKD-aP Hiding in Your Dialysis Center?
Elevating CKD-aP Care: New Frontier
CKD-aP or Something Else? Decoding the Diagnosis
The Critical Interplay: CKD, HF, and HyperkaleAmia
Javed Butler, MD
Patrick Rossignol, MD, PhD
Future Directions in Managing Hyperkalemia in CKD and HF
Javed Butler, MD, MPH, MBA
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Potassium Binders in Practice: Clinical Trial Evidence
Potassium Binders: Safety Comes First!
The Clinical Weight of TTR: What the Latest Data Reveal
Ahmad Masri, MD, MS
Rola Khedraki, MD, FACC
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
VNS: Beyond Seizure Control
Raman Sankar, MD, PhD
Scott Aaronson, MD